• Use of bone morphogenetic protein in lumbar fusion may yield high risk profile

    11 days ago - By Healio

    Use of bone morphogenetic protein in single-level lumbar fusion may have a higher risk profile than previously reported with non-significant benefits, according to results.
    Rown Parola, MS, and colleagues categorized 362,530 Medicare patients who underwent single-level lumbar fusion between 2004 and 2014 into groups based on whether they received bone morphogenetic protein .
    “The demographics and comorbidities were also identified by ICD-9 diagnosis code, and then we underwent propensity matching, trying to match our cohorts along the basis of age, Elixhauser comorbidity index, sex,
    Read more ...